Plain English Summary
Background and study aims.
Keyhole (laparoscopic) live donor kidney removal (nephrectomy) is now a well-established operation in the UK and Leicester was the first unit in the UK to perform this operation and has now carried out more than 400 of these procedures. The laparoscopic technique reduces post-operative pain and the need for pain relieving medication (analgesics) compared to the traditional open operation to remove kidneys, which was performed through quite a large incision. Nonetheless, some patients still require a reasonable amount of pain relieving medication, including intravenous injections of morphine after laparoscopic nephrectomy. We wish to study methods of decreasing the amount of post-operative pain even further.
We would like to investigate the use of a local anaesthetic technique called the transversus abdominis plane (TAP) block. This is a method of anaesthetising or numbing the nerve endings in the abdominal wall at the site of the operation incisions. It involves injecting a local anaesthetic agent into this region after the patient has gone to sleep under general anaesthetic and before the surgery begins. Previous studies have shown that this technique can reduce pain after operations such as caesarean section but there are no studies, so far, in patients undergoing kidney donation.
Who can participate?
Every patient over 18 years that has completed the full work-up for laparoscopic donor nephrectomy and is eligible will be approached for the trial. A total of 50 patients, 25 in each group will be required for the study.
What does the study involve?
In this study, patients undergoing a laparoscopic donor nephrectomy at Leicester General Hospital will be randomly allocated to have either the TAP block, with local anaesthetic (Bupivacaine), or a similar procedure with an inert salt solution (saline) that does not contain any anaesthetic (the control group). The study will be a so-called blinded one in which the patient, the surgeon and the anaesthetist are unaware whether local anaesthetic has been used or not in a particular patient.
Outcomes of the study will be judged primarily on the amount of pain relief that is required and the level of pain patients experience after surgery. Recover will also be assessed and any nausea, vomiting and drowsiness recorded. The duration of hospital stay and time to the introduction of free oral fluids and first solid food will also be recorded. Blood samples will also be taken to assess the effects of surgery.
What are the possible benefits and risks of participating?
This study will help to determine if the TAP block procedure is beneficial to patients undergoing laparoscopic live donor nephrectomy.
Both Bupivacaine anaesthetic and normal saline are routinely used in clinical practice and should cause no adverse effects. The TAP block procedure will be performed by a Consultant Anaesthetist who is experienced in the technique and giving anaesthetics for kidney donation. As the TAP block involves injections into the skin, it is possible that this will cause a small amount of bruising in the region but this is likely to be very minor. Local anaesthetics do have some adverse effects if they are injected directly into blood vessels. In the unlikely event of this happening, it is possible that there could be effects on the heart and on the nervous system. Precautions are taken to prevent injection of anaesthetics into blood vessels and the injections will also be performed using ultrasound guidance which, again, makes the procedure safer. There will be no long term risks from taking part in this study.
Where is the study run from?
Leicester General Hospital
When is the study starting and how long is it expected to run for?
The study will start in June 2010 and end in June 2012
Who is funding the study?
The University of Leicester, Transplant Department
Who is the main contact?
Professor Michael Nicholson
mln2@le.ac.uk
Trial website
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
UHL 10883
Study information
Scientific title
A randomised controlled trial of Transversus Abdominis Plane Block after laparoscopic live donor nephrectomy
Acronym
TAP Block Trial
Study hypothesis
The hypothesis to be tested in this study is that the use of a transversus abdominis plane (TAP) block will reduce post-operative pain and analgesic requirements in patients undergoing laparoscopic live donor nephrectomy.
Ethics approval
Leicestershire, Northamptonshire and Rutland Ethics Committee 1 approved on the 8th June 2010 (ref: 10/H0406/12)
Study design
Randomised single centre double-blinded placebo controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Hospitals
Trial type
Treatment
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Condition
Post-operative pain
Intervention
Patients will be randomised into one of two groups:
Group A: Bupivacaine local anaesthetic 20 ml 0.375% injected into the transversus abdominis plane at two sites before surgery
Group B: Placebo control; normal saline 20 ml 0.9% injected into the transversus abdominis plane at two sites before surgery
Follow up period of 7 days.
Intervention type
Other
Phase
Not Applicable
Drug names
Primary outcome measures
1. Total post-operative morphine requirement: post-operative analgesic use will be recorded by the nursing staff and pain team using the standard PCAS form. This will include the total dose of morphine used in mg.
2. Daily post-operative pain levels recorded using visual analogue and verbal response scales: 100 mm line with no pain at all written at the left hand (zero) end and worst pain imaginable written at the right hand (100) end. 0 = no pain at rest or movement; 1 = no pain at rest, slight at movement; 2 = intermittent pain at rest, moderate on movement; 3 = continuous pain at rest and severe on movement.
3. Total duration of PCAS use: post-operative analgesic use will be recorded by the nursing staff and pain team using the standard PCAS from. This will include the duration of PCAS use in hours.
Secondary outcome measures
1. Daily post-operative nausea and vomiting recorded using visual analogue and verbal response scales. 0 = no nausea and vomiting at rest or movement; 1 = no nausea and vomiting at rest, slight at movement; 2 = intermittent nausea and vomiting at rest, moderate on movement; 3 = continuous nausea and vomiting at rest and severe on movement.
2. Daily post-operative sedation recorded and scored as following: 0 = none, patient is alert; 1 = mild, awake but drowsy; 2 = moderate, asleep but rousable; 3 = severe, unrousable.
3. Adverse events caused by the TAP block procedure. These will include evidence of inflammation or infection at the administration sites or adverse effects of the local anaesthetic agent or saline.
4. Duration of post-operative stay. Patients will make their own decision about fitness for discharge from hospital. This decision will not be affected by the views of the medical and nursing team, except in the event of complications.
5. Time to the introduction of free oral fluids and the first solid food. Patients will make their own decision about the intake of fluids and solids. This decision will not be affected by the views of the medical and nursing team, except in the event of complications.
6. Timed up and go. Patients are timed as they rise from a chair, walk 3 metres, turn, walk back and sit. This will be measured before surgery and on post-operative days 1 and 3.
7. Grip strength. A hydraulic Hand Dynamometer is used to measuring grip strength (kg). The scores of 3 successive trials using the right and left hand will be measure before surgery and on each post-operative day until day 7 or at discharge, whichever is sooner.
8. Inflammation, cytokines (IL-1, IL-6 and TNF alpha). A blood sample will be taken pre-operatively and post-operatively at 6, 24 and 48 hours in addition to routine daily blood samples. The blood will be centrifuged and the plasma stored at -80°C until analysed.
Overall trial start date
23/06/2010
Overall trial end date
23/06/2012
Reason abandoned
Eligibility
Participant inclusion criteria
Patients will be eligible for the trial if ALL of the following criteria are met:
1. Aged 18 years or over, either sex
2. American Society of Anaesthesiology (ASA) grade 1 or 2
3. Individuals who have completed the full work-up for laparoscopic donor nephrectomy, including an assessment by the Human Tissue Authority
4. Written, signed informed consent to the trial
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
50
Participant exclusion criteria
Patients will NOT be eligible for the trial if ANY of the following criteria apply:
1. A history of relevant drug allergy
2. Patients receiving medical therapies considered to result in tolerance to opioids
3. Any condition which, in the opinion of the investigator, makes the patient unsuitable for entry into the study
Recruitment start date
23/06/2010
Recruitment end date
23/06/2012
Locations
Countries of recruitment
United Kingdom
Trial participating centre
Transplant Group
Leicester
LE5 4PW
United Kingdom
Sponsor information
Organisation
University of Leicester (UK)
Sponsor details
c/o Mr Graham Hewitt
School of Medicine
Medical School Office
Maurice Shock Building
PO Box 138
University Road
Leicester
LE1 9HN
United Kingdom
Sponsor type
University/education
Website
Funders
Funder type
Hospital/treatment centre
Funder name
University Hospitals of Leicester NHS Trust (UK)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Funder name
University of Leicester (UK)
Alternative name(s)
UoL
Funding Body Type
private sector organisation
Funding Body Subtype
academic
Location
United Kingdom
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary
1. 2012 results in http://www.ncbi.nlm.nih.gov/pubmed/22902793
Publication citations
-
Results
Hosgood SA, Thiyagarajan UM, Nicholson HF, Jeyapalan I, Nicholson ML, Randomized clinical trial of transversus abdominis plane block versus placebo control in live-donor nephrectomy., Transplantation, 2012, 94, 5, 520-525, doi: 10.1097/TP.0b013e31825c1697.